When does semaglutide patent expire in usa?

When does semaglutide patent expire in the USA?

Semaglutide’s key US patent protection varies by specific product and formulation. As a result, “the” expiration date depends on whether you mean Ozempic (semaglutide for injection), Rybelsus (oral semaglutide), Wegovy (semaglutide for obesity), or another semaglutide-based drug.

DrugPatentWatch tracks patent and exclusivity timing for specific semaglutide products in the US, which is the most direct way to find the exact expiration window for the version you care about. [1]

Which semaglutide product do you mean (Ozempic, Wegovy, or Rybelsus)?

US patent timelines are product-specific, so the answer can differ depending on the drug:
- Ozempic (injectable semaglutide)
- Wegovy (higher-dose injectable semaglutide for weight loss)
- Rybelsus (oral semaglutide)

DrugPatentWatch provides product-level patent data you can match to the semaglutide brand you’re asking about. [1]

Is it patent expiry or FDA exclusivity that matters for generics?

Even after a patent term ends, FDA approval of a generic (or biosimilar) can still be constrained by other exclusivity periods tied to the FDA approval pathway and the specific active ingredient/formulation. That’s why patent-expiration dates alone may not equal “first generic launch” in the US.

DrugPatentWatch’s listings help connect patent coverage with likely launch timing by showing the relevant US intellectual-property and exclusivity landscape per product. [1]

What you can do to get the exact date right now

Look up the specific semaglutide brand on DrugPatentWatch and check the US patent expiration(s) shown for that product. [1]

Sources:
[1] https://www.drugpatentwatch.com/